Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla, California developing first-in-class covalent protein biologics for cancer and other serious diseases. Its proprietary War-Lock technology uses engineered unnatural amino acids to enable protein drugs — including antibody-drug conjugates and T-cell engagers — to bind… - View it on GitHub